Utah Medical Products (NASDAQ:UTMD) Posts Quarterly Earnings Results

Utah Medical Products (NASDAQ:UTMD) announced its quarterly earnings results on Tuesday. The medical instruments supplier reported $0.86 EPS for the quarter, Zacks reports. Utah Medical Products had a return on equity of 12.10% and a net margin of 34.62%.

Utah Medical Products Trading Down 1.8 %

UTMD opened at $63.00 on Wednesday. Utah Medical Products has a 12 month low of $60.08 and a 12 month high of $83.05. The stock has a 50-day moving average of $62.82 and a 200 day moving average of $65.62. The firm has a market cap of $213.57 million, a P/E ratio of 14.75 and a beta of 0.09.

Utah Medical Products Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 3rd. Investors of record on Monday, December 16th were issued a $0.305 dividend. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Monday, December 16th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 1.94%. Utah Medical Products’s dividend payout ratio (DPR) is presently 28.57%.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.